• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉旁路移植术与经皮冠状动脉介入治疗急性心力衰竭。

Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.

机构信息

Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

出版信息

Heart. 2020 Jan;106(1):50-57. doi: 10.1136/heartjnl-2018-313242. Epub 2018 Sep 12.

DOI:10.1136/heartjnl-2018-313242
PMID:30209124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6952823/
Abstract

OBJECTIVE

Myocardial ischaemia is a leading cause of acute heart failure (AHF). However, optimal revascularisation strategies in AHF are unclear. We aimed to compare two revascularisation strategies, coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI), in patients with AHF.

METHODS

Among 5625 consecutive patients enrolled prospectively in the Korean Acute Heart Failure registry from March 2011 to February 2014, 717 patients who received CABG or PCI during the index hospitalisation for AHF were included in this analysis. We compared adverse outcomes (death, rehospitalisation for HF aggravation or cardiovascular causes, ischaemic stroke and a composite outcome of death and rehospitalisation for HF aggravation or cardiovascular causes) with the use of propensity score matching.

RESULTS

For the propensity score-matched cohort with 190 patients, CABG had a lower risk of all-cause mortality than PCI (83 vs 147 deaths per 1000 patient-years; HR 0.57, 95% CI 0.34 to 0.96, p=0.033) during the median follow-up of 4 years. There was also a trend towards lower rates of rehospitalisation due to cardiovascular events or HF aggravation. Subgroup analysis revealed that the adverse outcomes were significantly lower in the CABG group than in PCI group, especially in patients with old age, three-vessel diseases, significant proximal left anterior descending artery disease and those without left main vessel disease or chronic total occlusion.

CONCLUSIONS

Compared with PCI, CABG is associated with significant lower all-cause mortality in patients with AHF. Further studies should evaluate proper revascularisation strategies in AHF.

CLINICAL TRIAL REGISTRATION

NCT01389843; Results.

摘要

目的

心肌缺血是急性心力衰竭(AHF)的主要原因。然而,AHF 的最佳血运重建策略仍不明确。我们旨在比较两种血运重建策略,即冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI),在 AHF 患者中的应用。

方法

在 2011 年 3 月至 2014 年 2 月期间前瞻性纳入的韩国急性心力衰竭注册研究的 5625 例连续患者中,有 717 例患者在 AHF 指数住院期间接受了 CABG 或 PCI,本分析纳入了这部分患者。我们比较了使用倾向评分匹配后的不良结局(死亡、因 HF 加重或心血管原因再住院、缺血性卒中和死亡和因 HF 加重或心血管原因再住院的复合结局)。

结果

在 190 例倾向评分匹配患者的队列中,在中位随访 4 年期间,CABG 的全因死亡率低于 PCI(每 1000 例患者年分别为 83 例和 147 例死亡;HR 0.57,95%CI 0.34 至 0.96,p=0.033)。因心血管事件或 HF 加重而再住院的发生率也呈下降趋势。亚组分析显示,CABG 组的不良结局明显低于 PCI 组,尤其是在老年、三血管疾病、左前降支近端显著病变和无左主干病变或慢性完全闭塞的患者中。

结论

与 PCI 相比,CABG 与 AHF 患者的全因死亡率显著降低相关。需要进一步的研究来评估 AHF 患者的适当血运重建策略。

临床试验注册号

NCT01389843;结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/6952823/84fe36c6916a/heartjnl-2018-313242f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/6952823/9ebfc620a8f6/heartjnl-2018-313242f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/6952823/84fe36c6916a/heartjnl-2018-313242f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/6952823/9ebfc620a8f6/heartjnl-2018-313242f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/6952823/84fe36c6916a/heartjnl-2018-313242f02.jpg

相似文献

1
Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.冠状动脉旁路移植术与经皮冠状动脉介入治疗急性心力衰竭。
Heart. 2020 Jan;106(1):50-57. doi: 10.1136/heartjnl-2018-313242. Epub 2018 Sep 12.
2
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.DELTA 注册研究:非保护左主干冠状动脉开口/中段病变行经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期临床结果:多中心注册研究评估左主干病变的经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗
JACC Cardiovasc Interv. 2014 Apr;7(4):354-61. doi: 10.1016/j.jcin.2013.11.014. Epub 2014 Mar 14.
3
Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.冠状动脉旁路移植术与经皮冠状动脉介入治疗在无保护左主干冠状动脉疾病患者中的应用。
JACC Cardiovasc Interv. 2016 Jun 13;9(11):1102-11. doi: 10.1016/j.jcin.2016.03.039.
4
Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.男性和女性无保护左主干病变患者行冠状动脉支架置入术或旁路手术的结果:EXCEL 试验。
JACC Cardiovasc Interv. 2018 Jul 9;11(13):1234-1243. doi: 10.1016/j.jcin.2018.03.051.
5
B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.B 型利钠肽评估在左主干冠状动脉疾病血运重建患者中的应用:来自 EXCEL 试验的分析。
Circulation. 2018 Jul 31;138(5):469-478. doi: 10.1161/CIRCULATIONAHA.118.033631.
6
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局:DELTA 注册研究(左主干冠状动脉疾病药物洗脱支架):一项多中心注册研究,评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
7
Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.在涉及左冠状动脉前降支近端的多支血管病变中,冠状动脉搭桥手术与支架置入术的比较
Heart. 2017 Mar;103(6):428-433. doi: 10.1136/heartjnl-2016-309720. Epub 2016 Sep 20.
8
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
9
Prior Coronary Artery Bypass Graft Surgery and Outcome After Percutaneous Coronary Intervention: An Observational Study From the Pan-London Percutaneous Coronary Intervention Registry.经皮冠状动脉介入治疗前冠状动脉旁路移植术和经皮冠状动脉介入治疗后的结果:来自泛伦敦经皮冠状动脉介入治疗登记处的观察性研究。
J Am Heart Assoc. 2020 Jun 16;9(12):e014409. doi: 10.1161/JAHA.119.014409. Epub 2020 Jun 1.
10
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.SYNTAX 试验中发生的卒中分析:冠状动脉旁路移植术与经皮冠状动脉介入治疗治疗复杂冠状动脉疾病的比较。
JACC Cardiovasc Interv. 2013 Apr;6(4):344-54. doi: 10.1016/j.jcin.2012.11.010. Epub 2013 Mar 20.

引用本文的文献

1
Current Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review.缺血性收缩性心力衰竭中冠状动脉血运重建的现状与未来方向:综述
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101197. doi: 10.1016/j.jscai.2023.101197. eCollection 2023 Nov-Dec.
2
The Current State of Coronary Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Interventions.冠状动脉血运重建的现状:冠状动脉旁路移植术与经皮冠状动脉介入治疗。
Curr Cardiol Rep. 2024 Sep;26(9):919-933. doi: 10.1007/s11886-024-02090-x. Epub 2024 Jul 10.
3
Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?

本文引用的文献

1
Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.比较严重冠状动脉疾病患者完全血运重建患者中支架置入术与旁路移植术的疗效:SYNTAX、PRECOMBAT 和 BEST 临床试验的患者水平汇总分析
JACC Cardiovasc Interv. 2017 Jul 24;10(14):1415-1424. doi: 10.1016/j.jcin.2017.04.037.
2
Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF).韩国急性心力衰竭的临床特征与转归:韩国急性心力衰竭注册研究(KorAHF)结果
Korean Circ J. 2017 May;47(3):341-353. doi: 10.4070/kcj.2016.0419. Epub 2017 May 25.
3
心力衰竭治疗的范式转变:我们是否需要另一种范式?
Int J Heart Fail. 2020 Apr 6;2(3):145-156. doi: 10.36628/ijhf.2020.0010. eCollection 2020 Jul.
4
A comparison of drug-eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure.药物洗脱支架与冠状动脉旁路移植术治疗轻中度缺血性心力衰竭的比较。
ESC Heart Fail. 2022 Jun;9(3):1749-1755. doi: 10.1002/ehf2.13852. Epub 2022 Feb 22.
5
Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease.心力衰竭对严重冠状动脉疾病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术后长期临床结局的影响。
J Am Heart Assoc. 2021 Aug 3;10(15):e021257. doi: 10.1161/JAHA.121.021257. Epub 2021 Jul 29.
6
Residual Gensini Score Is Associated With Long-Term Cardiac Mortality in Patients With Heart Failure After Percutaneous Coronary Intervention.残余Gensini评分与经皮冠状动脉介入治疗后心力衰竭患者的长期心脏死亡率相关。
Circ Rep. 2020 Jan 28;2(2):89-94. doi: 10.1253/circrep.CR-19-0121.
7
Coronary Artery Bypass Graft Surgery Improves Survival Without Increasing the Risk of Stroke in Patients with Ischemic Heart Failure in Comparison to Percutaneous Coronary Intervention: A Meta-Analysis With 54,173 Patients.与经皮冠状动脉介入治疗相比,冠状动脉旁路移植术可提高缺血性心力衰竭患者的生存率且不增加中风风险:一项纳入54173例患者的荟萃分析
Braz J Cardiovasc Surg. 2019 Aug 27;34(4):396-405. doi: 10.21470/1678-9741-2019-0170.
8
Myocardial ischemia and coronary disease in heart failure.心力衰竭中的心肌缺血和冠状动脉疾病。
Heart Fail Rev. 2020 Jan;25(1):53-65. doi: 10.1007/s10741-019-09831-z.
9
Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure.心力衰竭患者最新冠状动脉血运重建的当前实践。
Braz J Cardiovasc Surg. 2019 Jan-Feb;34(1):93-97. doi: 10.21470/1678-9741-2018-0335.
10
Coronary Artery Bypass Grafting in Acute Ischemic Heart Failure: Where do We Stand? (And Where Should We Go?).急性缺血性心力衰竭中的冠状动脉旁路移植术:我们现状如何?(以及我们应何去何从?)
Braz J Cardiovasc Surg. 2018 Sep-Oct;33(5):II-III. doi: 10.21470/1678-9741-2018-0329.
Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry.
亚洲心力衰竭患者的区域和种族差异:亚洲心力衰竭中的心脏性猝死注册研究。
Eur Heart J. 2016 Nov 1;37(41):3141-3153. doi: 10.1093/eurheartj/ehw331. Epub 2016 Aug 7.
4
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
5
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的冠状动脉搭桥手术
N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3.
6
Trial of everolimus-eluting stents or bypass surgery for coronary disease.瑞舒伐他汀洗脱支架置入术或冠状动脉旁路移植术治疗冠心病的临床试验
N Engl J Med. 2015 Mar 26;372(13):1204-12. doi: 10.1056/NEJMoa1415447. Epub 2015 Mar 16.
7
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Dec 23;130(25):e344-426. doi: 10.1161/CIR.0000000000000134. Epub 2014 Sep 23.
8
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
9
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗对三血管病变患者的比较:SYNTAX 试验的最终五年随访结果。
Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.
10
A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry.一项针对韩国急性心力衰竭综合征的多中心队列研究:韩国急性心力衰竭(KorAHF)注册研究的原理、设计和中期观察。
Eur J Heart Fail. 2014 Jun;16(6):700-8. doi: 10.1002/ejhf.91. Epub 2014 May 2.